Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

INDUSTRY 4OTHER 2OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Rectal Neoplasms 8Stomach Neoplasms 5Nasopharyngeal Carcinoma 4Colorectal Neoplasms 4Breast Neoplasms 4Esophageal Neoplasms 3Neoplasm Metastasis 2Colonic Neoplasms 2Breast Cancer Metastatic 2Adenocarcinoma 2Triple Negative Breast Neoplasms 1Pancreatic Neoplasms 1Oesophagogastric Cancer 1Neuroendocrine Tumors 1Nasopharyngeal Neoplasms 1Mid-low Rectal Cancer 1Metastatic Breast Cancer in the Brain 1Locally Advanced Rectal Cancer With Liver Metastases 1Locally Advanced Rectal Cancer 1Liver Metastases of Colorectal Cancer 1Immunotherapy 1HER2 Positive Metastatic Breast Cancer 1Colorectal Cancer Liver Metastasis 1Cholangiocarcinoma 1Advanced Breast Cancer 1

Interventions

Fluorouracil 3Cisplatin 3Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER_GOV × Nasopharyngeal Neoplasms × Capecitabine × Clear all
NCT00577057 2013-08-22

Benefit of Changing Chemoradiotherapy Sequence and Modifying Radiotherapy Schedule for Advanced Nasopharyngeal Cancer

Hospital Authority, Hong Kong

Phase NA Unknown
798 enrolled
Head & Neck

Nasopharyngeal Carcinoma, Nasopharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡